首站-论文投稿智能助手
典型文献
Neutrophils inhibit CD8+ T cells immune response by arginase-1 signaling in patients with sepsis
文献摘要:
BACKGROUND: Patients with sepsis often exhibit an acute inflammatory response, followed by an immunosuppressive phase with a poor immune response. However, the underlying mechanisms have not been fully elucidated. METHODS: We sought to comprehensively characterize the transcriptional changes in neutrophils of patients with sepsis by transcriptome sequencing. Additionally, we conducted a series of experiments, including real-time quantitative polymerase chain reaction (RT-qPCR) and flow cytometry to investigate the role of arginase-1 signaling in sepsis. RESULTS: Through the analysis of gene expression profiles, we identified that the negative regulation of T cell activation signaling was enriched, and the expression of arginase-1 was high in neutrophils from patients with sepsis. Furthermore, we conducted flow cytometry and found that the function of CD8+ T cells in septic patients was impaired. Moreover, neutrophils from septic patients inhibited the percentage of polyfunctional effector CD8+ T cells through arginase-1. Additionally, the proportions of granzyme B+IFN-γ+CD8+ T and TNF-α+IFN-γ+CD8+ T cells increased after inhibition of arginase-1 signaling. CONCLUSION: The impaired effector function of CD8+ T cells could be restored by blocking arginase-1 signaling in patients with sepsis.
文献关键词:
作者姓名:
Xiao-kang Dai;Zhen-xing Ding;Yuan-yuan Tan;Hua-rui Bao;Dong-yao Wang;Hong Zhang
作者机构:
Department of Emergency,the First Affiliated Hospital of Anhui Medical University,Hefei 230027,China;Department of Hematology,the First Affiliated Hospital of University of Science and Technology of China,Division of Life Sciences and Medicine,Hefei 230001,China;Division of Molecular Medicine,Hefei National Laboratory for Physical Sciences at Microscale,the Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease,School of Life Sciences,University of Science and Technology of China,Hefei 230001,China;Anhui Province Key Laboratory of Immunology in Chronic Diseases,Bengbu Medical College,Bengbu 233030,China
引用格式:
[1]Xiao-kang Dai;Zhen-xing Ding;Yuan-yuan Tan;Hua-rui Bao;Dong-yao Wang;Hong Zhang-.Neutrophils inhibit CD8+ T cells immune response by arginase-1 signaling in patients with sepsis)[J].世界急诊医学杂志(英文),2022(04):266-273
A类:
B+IFN,+CD8+
B类:
Neutrophils,cells,immune,response,by,arginase,signaling,patients,sepsis,BACKGROUND,Patients,often,exhibit,acute,inflammatory,followed,immunosuppressive,phase,poor,However,underlying,mechanisms,have,not,been,fully,elucidated,METHODS,We,sought,comprehensively,characterize,transcriptional,changes,neutrophils,transcriptome,sequencing,Additionally,conducted,series,experiments,including,real,quantitative,polymerase,chain,reaction,qPCR,flow,cytometry,investigate,role,RESULTS,Through,analysis,gene,expression,profiles,identified,that,negative,regulation,activation,was,enriched,high,from,Furthermore,found,septic,impaired,Moreover,inhibited,percentage,polyfunctional,effector,through,proportions,granzyme,increased,after,inhibition,CONCLUSION,could,restored,blocking
AB值:
0.516218
相似文献
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/ BRAF/TAK1/ERK/ETV4 signaling
Panpan Ma;Xinxin Jin;Zhiwei Fan;Zhou Wang;Suhui Yue;Changyue Wu;Shiyin Chen;Yuanyuan Wu;Miaomiao Chen;Donghua Gu;Siliang Zhang;Renfang Mao;Yihui Fan-Laboratory of Medical Science,School of Medicine,Nantong University,Nantong 226001,China;Department of Pathogenic Biology,School of Medicine,Nantong University,Nantong 226001,China;Department of Clinical Laboratory,Yancheng No.1 People's Hospital,Yancheng 224005,China;School of Life Sciences,Nantong University,Nantong 226001,China;Department of Dermatology,Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Urology,the Second Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Radiotherapy Oncology,Harbin Medical University Cancer Hospital,Harbin 150086,China;Department of Pathophysiology,School of Medicine,Nantong University,Nantong 226001,China
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Implication of a novel truncating mutation in titin as a cause of autosomal dominant left ventricular noncompaction
Xue-Qi DONG;Di ZHANG;Yi QU;Yu-Xiao HU;Chun-Xue YANG;Tao TIAN;Nan XU;Hai-Lun JIANG;Li ZENG;Peng-Yan XIA;Ya-Xin LIU;Rui LIU;Xian-Liang ZHOU-Department of Cardiology,Fuwai Hospital,National Center for Cardiovascular Disease,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;Department of Echocardiography,Fuwai Hospital,Natio-nal Center for Cardiovascular Disease,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Science,Beijing,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。